Cancer Patients Getting Free Golf Memberships

Here's a fantastic idea: In an effort to bolster the physical and spiritual health of cancer patients while they undergo chemotherapy and other treatments, local athletic establishments should offer them temporary free memberships. The patients benefit by staying active and keeping their minds off their treatments, the establishments benefit by scoring good local PR.

Of course, it's not my idea. Rather, it's what's happening at the Sanctuary Golf Club in North Canton, Ohio, according to a piece at CantonRep.com.

Cancer patients receiving treatment at one of three local hospitals (Aultman, Mercy Medical Center or North Canton Medical Foundation) can go to their doctor's (oncologist) office and ask for a free membership card. These cards have to bear the signature of their doctor or staff. Beyond that, there are no other requirements.

More information is available by calling a cancer center at one of the following hospitals:

  • Aultman: (330) 452-9911
  • Mercy Medical Center: (330) 430-2788
  • North Canton Medical Foundation: (330) 438-6333

The Sanctuary Golf Club can be reached at (330) 499-7721.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap